The 21st Century Cures Act, proposed by Representatives Fred Upton (R-MI) and Diana DeGette (D-DO), was signed into law by President Barack ...

Provider organizations have taken big strides towards personalization. According to the Redpoint Global Survey, 75% of consumers in the United ...

Centralized monitoring has become a popular approach in on-site and off-site monitoring plans for clinical trials as technological progression enables ...

As businesses scrambled to move operations into the virtual office at the onset of the global COVID-19 pandemic, life sciences ...

The drug research and development (R&D) cycle and supply chain for pharmaceuticals have been thrust into the spotlight by the ...

Increased globalization and the growing complexities around innovative, next-generation therapies has forced biopharmaceutical leaders to reexamine their clinical supply chain ...

In the age of precision and personalized medicine, life science companies can develop treatments designed to target almost any patient’s ...

The promising outlook for liquid biopsy diagnosis has sparked the interest of many in the biotech industry. The speed, ease, ...

Clinical trial design, like much of the industry, is experiencing a wave of innovation and disruption. Classical randomized control trials ...

A paper published this month proving that the use of RNA transposons can improve the CRISPR process has excited the ...

Clinical trials have long been viewed as complicated and high-volume endeavors, involving the widespread recruitment of patients, supply chain planning ...

The most innovative organizations have demonstrated their success stems from creative strategy paired with iterative and efficient execution. It’s all ...